Advancing Personalized Medicine through whole-genome profiling

DATE:  September 29, 2016
TIME:  10:00am PT, 1:00pm ET

One of the challenges with personalized medicine lies in the identification of robust, clinically relevant biomarkers. Traditional approaches to biomarker discovery either focus on only a subset of the potential targets, or have insufficient resolution to discriminate small or rare changes that may carry biological significance.

Recent technological advancement has made high-resolution whole-genome and whole-transcriptome profiling a reality. Translational researchers can now simultaneously search broadly and deeply to efficiently identify potential biomarkers from samples in a matter of days, without requiring resource-intensive bioinformatics support.

During the webinar, Dr. Stewart Neill will:

• Discuss the importance of copy number variation and copy-neutral loss of heterozygosity in the modern classification and subclassification of CNS neoplasia
• Demonstrate how advancements in technologies with greater sensitivity can detect important cytogenomic events that are driving the discovery of novel biomarkers
• Illustrate the use of microarray-based technologies in a clinical research setting through a case study approach
• Answer your questions live during the broadcast!